What Is Testosterone Replacement Therapy?
Testosterone is far more than a hormone associated with masculinity or athletic performance. It plays a foundational role in energy regulation, muscle and bone maintenance, mood, cognitive function, libido, and metabolic health in both men and women. When testosterone levels decline, the effects can be wide-ranging and deeply affect quality of life.
Testosterone replacement therapy, commonly referred to as TRT, is a medical treatment designed to restore testosterone to levels that support normal physiological function. It has become increasingly common, particularly among men over 40, and is now one of the more frequently discussed topics at the intersection of longevity medicine and cardiovascular care.
As its use has grown, so has an important and still-evolving question: what does TRT mean for the heart?
Who Is a Candidate for TRT?
TRT is prescribed for individuals with clinically low testosterone, a condition known as hypogonadism. This is not simply a matter of feeling tired or less energetic than in younger years. A legitimate diagnosis involves both symptoms and confirmed blood test results showing testosterone levels below established thresholds.
Common symptoms that may prompt evaluation include:
- Persistent fatigue or low energy
- Reduced libido or sexual dysfunction
- Loss of muscle mass and increased body fat
- Mood changes, including depression or irritability
- Difficulty concentrating or mental fogginess
- Decreased bone density
- Poor sleep quality
It is important to note that low testosterone can be caused by primary testicular dysfunction, or by secondary causes involving the pituitary or hypothalamus. Identifying the underlying reason matters because it shapes treatment decisions.
TRT is also used in women, though at much lower doses, to address symptoms such as low libido, fatigue, and loss of vitality that may arise during or after menopause. The cardiovascular implications in women are somewhat different and still an active area of research.
How Is TRT Administered?
Testosterone replacement is available in several forms, each with different absorption profiles, dosing schedules, and practical considerations.
- Intramuscular or subcutaneous injections: Administered weekly or biweekly, injections deliver testosterone directly into the muscle or under the skin. They are cost-effective and reliable but involve fluctuations in hormone levels between doses.
- Topical gels and creams: Applied daily to the skin, these allow for more stable hormone levels but carry a small risk of transference to others through skin contact.
- Transdermal patches: Worn on the skin and changed daily, patches offer a steady delivery mechanism with moderate convenience.
- Pellets: Small pellets implanted under the skin release testosterone slowly over several months, offering stable levels without daily or weekly administration.
- Oral formulations: Newer oral testosterone options have become available and are designed to bypass the liver metabolism issues associated with older oral versions.
The choice of delivery method is individualized based on patient preference, lifestyle, cost, and clinical considerations, including cardiovascular risk profile.
What Does Testosterone Do in the Cardiovascular System?
Testosterone has complex, bidirectional interactions with the cardiovascular system that researchers are still working to fully characterize. On one hand, testosterone supports several aspects of cardiovascular health. It contributes to red blood cell production, influences vascular tone, supports lean muscle mass, and plays a role in insulin sensitivity. Low testosterone has been independently associated with an increased risk of metabolic syndrome, type 2 diabetes, and cardiovascular disease.
On the other hand, supraphysiologic levels of testosterone, meaning levels well above the normal physiological range, are associated with adverse cardiovascular effects. This is particularly relevant in the context of anabolic steroid abuse, which involves doses dramatically higher than those used in medically supervised TRT.
The cardiovascular question for TRT specifically is whether restoring testosterone to normal physiological levels is neutral, beneficial, or harmful for the heart. The answer, as with many things in medicine, is nuanced.
What Does the Research Say?
The cardiovascular safety of TRT has been studied extensively, and the findings have evolved considerably over time.
Earlier observational studies raised concerns about potential increases in heart attack and stroke risk, particularly in older men with pre-existing cardiovascular disease. These findings generated significant caution and, in some cases, alarm.
More recent and rigorous research has told a more reassuring, though still complex, story. A landmark clinical trial known as the TRAVERSE study, published in 2023, followed men with hypogonadism and elevated cardiovascular risk over several years. The study found that TRT did not significantly increase the rate of major adverse cardiovascular events compared to placebo in this population.
However, the same trial identified a higher incidence of atrial fibrillation, pulmonary embolism, and acute kidney injury in the TRT group, findings that underscore the importance of careful patient selection and ongoing monitoring.
The current consensus among cardiovascular and endocrine specialists is that TRT, when used appropriately in men with confirmed hypogonadism, managed at physiological doses, and overseen with proper monitoring, does not appear to substantially increase the risk of heart attack or stroke in most individuals. But it is not without nuance, and certain patients require more careful consideration.
What Are the Specific Cardiac Concerns with TRT?
Several mechanisms have been identified through which testosterone, particularly at elevated levels, may influence cardiovascular risk.
Erythrocytosis. Testosterone stimulates red blood cell production. When hematocrit, the proportion of red blood cells in the blood, rises too high, blood becomes more viscous and harder for the heart to pump efficiently. This increases the risk of clotting events including deep vein thrombosis and pulmonary embolism. Regular monitoring of blood counts is essential for anyone on TRT.
Atrial fibrillation. As noted in the TRAVERSE trial, TRT may be associated with a modestly increased risk of atrial fibrillation, an irregular heart rhythm that raises stroke risk. The mechanism is not fully understood but may relate to testosterone's influence on cardiac electrical conduction.
Fluid retention. Testosterone can cause the body to retain sodium and water, which may elevate blood pressure and increase the workload on the heart, particularly in individuals with pre-existing hypertension or heart failure.
Lipid effects. TRT can lower HDL cholesterol in some individuals, which is generally considered an unfavorable change from a cardiovascular standpoint. The clinical significance of this effect within the context of overall cardiovascular risk management is still being evaluated.
Left ventricular changes. Some studies have suggested that long-term TRT may be associated with modest changes in left ventricular mass, though whether this translates to meaningful clinical risk at physiological doses remains an open question.
Who Should Be Most Cautious About TRT?
Not everyone with low testosterone is an equal candidate for TRT. Certain individuals warrant more careful evaluation and may require additional monitoring or alternative strategies.
- Men with a recent history of heart attack or stroke
- Individuals with poorly controlled heart failure
- Those with a personal or family history of blood clots or clotting disorders
- Men with significant sleep apnea that is not being adequately treated
- Individuals with elevated hematocrit at baseline
- Those with certain hormone-sensitive conditions
For these patients, the decision to pursue TRT should involve a detailed cardiovascular risk assessment and, ideally, a collaborative conversation between the prescribing physician and a cardiologist.
The Case for Cardiovascular Monitoring During TRT
Regardless of baseline risk, anyone on TRT benefits from ongoing cardiovascular monitoring. This is not a treatment that can be initiated and left unattended. A responsible TRT protocol includes:
- Regular blood counts to monitor hematocrit and hemoglobin
- Blood pressure tracking
- Lipid panel monitoring
- Testosterone level measurement to ensure dosing remains within the physiological range
- Periodic cardiovascular assessment, including symptom review and appropriate imaging or testing based on individual risk
In a concierge cardiology setting, this kind of vigilant, personalized monitoring is built into the care relationship rather than left to chance or fragmented across multiple providers.
TRT, Longevity Medicine, and the Precision Approach
TRT sits at an interesting crossroads in the growing world of longevity and performance medicine. For men and women who are experiencing genuine hormonal deficiency, restoring physiological testosterone levels may support energy, metabolic health, body composition, and overall vitality in ways that are meaningful and real.
At the same time, testosterone is not a supplement to be taken casually or optimized without regard for the cardiovascular system. The heart has to live with every hormonal decision made in its vicinity.
This is exactly the kind of clinical complexity that Dr. Ilan Kedan navigates at Cardiolucent in Beverly Hills. For patients who are considering TRT, already on it, or wondering whether their current protocol is being managed with sufficient cardiovascular oversight, a precision medicine evaluation provides clarity. Advanced diagnostics, a thorough review of hormonal and cardiovascular risk factors, and a care plan that integrates all of the relevant clinical variables allow for decisions that are genuinely informed rather than simply convenient.
Final Thoughts
Testosterone replacement therapy is neither a cardiovascular villain nor a guaranteed path to vitality. Like most things in medicine, its impact depends enormously on who is using it, how it is managed, and whether the right monitoring is in place.
For individuals with confirmed hypogonadism who are good candidates for treatment, TRT can be part of a thoughtful health strategy when overseen with appropriate cardiovascular care. For those with existing heart conditions or elevated risk, the conversation requires more careful navigation.
The heart does not exist in isolation from the rest of the body. Every hormonal decision affects it. Every treatment choice should account for it.
Because optimizing how you feel today should never come at the cost of how your heart performs tomorrow.